发明公开
- 专利标题： ENHANCED ABSORPTION OF MODIFIED RELEASE DOSAGE FORMS
- 专利标题（中）： 改善的吸收剂型改良释放
-
申请号： EP04815260.7申请日： 2004-12-23
-
公开(公告)号： EP1701705A2公开(公告)日： 2006-09-20
- 发明人: TREACY, Donald, J., Jr. , FLANNER, Henry, H. , GUTTENDORF, Robert , BURNSIDE, Beth
- 申请人： Advancis Pharmaceutical Corporation
- 申请人地址： 20425 Seneca Meadows Parkway Germantown, MD 2087678 US
- 专利权人： Advancis Pharmaceutical Corporation
- 当前专利权人： Advancis Pharmaceutical Corporation
- 当前专利权人地址： 20425 Seneca Meadows Parkway Germantown, MD 2087678 US
- 代理机构： Walcher, Armin
- 优先权： US532772P 20031224
- 国际公布： WO2005062898 20050714
- 主分类号： A61K9/20
- IPC分类号： A61K9/20 ; A61K9/48
摘要：
Disclosed are products and methods for improving the plasma profile in a patient being treated with a pharmaceutical active agent that is subject to a limited window of absorption, which products and methods comprise orally administering the active agent in multiparticulate form, such that at least a portion thereof is delivered to the intestine while the patient is in the fed condition.
信息查询
